Latest rheumatoid arthritis Stories
Primary Efficacy Analysis Demonstrates Clinical Equivalence THOUSAND OAKS, Calif., Feb.
BAUDETTE, Minn., Jan. 30, 2015 /PRNewswire/ -- ANI Pharmaceuticals, Inc.
-33% rate of DAS28-CRP remission or low disease activity reported in Phase 2a cohort- MONROVIA, Calif., Jan. 29, 2015 /PRNewswire/ -- Xencor, Inc.
Beverly Hills rheumatologist Dr.
-- First biosimilar from Samsung Bioepis to advance to EMA regulatory review -- INCHEON, South Korea, Jan.
Recent work which suggests that depression is a kind of allergic reaction affecting the immune system might just help.
NORWALK, Conn., Jan.
The estimated global market of Rheumatoid Arthritis is expected to reach $38B in 2017 PETACH TIKVA, Israel, Dec.
New report from Kantar Health shows opportunities for biosimilars are high in oncology, low in rheumatoid arthritis in China. Shanghai, China (PRWEB) December
- The parings of haberdine; also, any kind of fragments.